Linda M Rubinstein
CIK 1321937 · CHIEF FINANCIAL OFFICER · last filed 2025-12-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
11
Lifetime Open-Market Net
$145.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | CHIEF FINANCIAL OFFICER | 61,150 | $4.36 | $266.6K | $145.5K | 7 | 2025-12-10 |
| BIOCEPT INC (BIOC) Delisted | Director | — | $0.43 | — | $0 | 2 | 2022-09-08 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-01-30 | — | Disp (D) | — | $0 |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.